The above diagram shows the color scheme of the layout in the main result page. The parent entities and officers are those entities, including individual and legal persons, have significant controls over the company in focus. The offspring entities and appointments are those entities that the company in focus can influence on.

Clicking the links on parent entities or officers, and offspring entities or managed companies will put them in focus and show upstream or downstream connections. In general, ascendant entities can be found by moving toward upstream, and descendant entities are by toward downstream. In this way, progenitor entities such as grandparent companies (parents of parent), sibling companies (children of parent), partner companies (parents of child), and progeny entities such as grandchild companies (children of child) can be found easily.

Parent entities and officers
Active 3
  • 1
    Hedgeland, Paul Frederick
    Director born in February 1947
    Individual (4 offsprings)
    Officer
    2019-11-19 ~ now
    OF - director → CIF 0
  • 2
    Singh, Naseeb
    Investment Director born in March 1983
    Individual (5 offsprings)
    Officer
    2020-01-08 ~ now
    OF - director → CIF 0
  • 3
    Orsi, Nadia, Dr
    Ceo born in October 1977
    Individual (10 offsprings)
    Officer
    2012-12-07 ~ now
    OF - director → CIF 0
Ceased 7
  • 1
    Wright, Edwina Mary, Dr.
    Business Consultant born in April 1960
    Individual (2 offsprings)
    Officer
    2012-12-07 ~ 2017-06-01
    OF - director → CIF 0
  • 2
    Mckinley, John Aiken
    Solicitor, Director born in June 1954
    Individual (9 offsprings)
    Officer
    2020-08-01 ~ 2022-11-25
    OF - director → CIF 0
  • 3
    Round, Andrew Edward, Dr
    Investment Director born in February 1974
    Individual (7 offsprings)
    Officer
    2018-04-11 ~ 2019-10-23
    OF - director → CIF 0
  • 4
    Danson, David Laurence George, Dr
    Retired born in September 1945
    Individual (2 offsprings)
    Officer
    2015-11-20 ~ 2020-03-31
    OF - director → CIF 0
  • 5
    Norris, Michael John
    Accountant born in March 1964
    Individual (28 offsprings)
    Officer
    2013-05-08 ~ 2015-11-20
    OF - director → CIF 0
  • 6
    131, Mount Pleasant, Liverpool, England
    Dissolved corporate (2 parents, 4 offsprings)
    Equity (Company account)
    1 GBP2021-12-31
    Officer
    2013-03-28 ~ 2016-09-13
    PE - director → CIF 0
  • 7
    Drury House, 19 Water Street, Liverpool, England
    Corporate
    Person with significant control
    2016-04-06 ~ 2019-10-04
    PE - Ownership of shares – More than 25% but not more than 50% → CIF 0
    PE - Ownership of voting rights - More than 50% but less than 75% → CIF 0
parent relation
Company in focus

OSTARA BIOMEDICAL LIMITED

Standard Industrial Classification
74909 - Other Professional, Scientific And Technical Activities N.e.c.
Brief company account
Intangible Assets
1,345,232 GBP2022-01-31
1,326,492 GBP2021-03-31
Property, Plant & Equipment
2,003 GBP2022-01-31
2,343 GBP2021-03-31
Fixed Assets
1,347,235 GBP2022-01-31
1,328,835 GBP2021-03-31
Debtors
12,952 GBP2022-01-31
78,914 GBP2021-03-31
Cash at bank and in hand
57,813 GBP2022-01-31
304,713 GBP2021-03-31
Current Assets
70,765 GBP2022-01-31
383,627 GBP2021-03-31
Net Current Assets/Liabilities
-4,901 GBP2022-01-31
310,882 GBP2021-03-31
Total Assets Less Current Liabilities
1,342,334 GBP2022-01-31
1,639,717 GBP2021-03-31
Net Assets/Liabilities
1,342,334 GBP2022-01-31
1,639,717 GBP2021-03-31
Equity
Called up share capital
1,083 GBP2022-01-31
1,083 GBP2021-03-31
Share premium
3,197,851 GBP2022-01-31
3,197,851 GBP2021-03-31
Retained earnings (accumulated losses)
-1,856,600 GBP2022-01-31
-1,559,217 GBP2021-03-31
Average number of employees in administration and support functions
22021-04-01 ~ 2022-01-31
22020-04-01 ~ 2021-03-31
Average Number of Employees
22021-04-01 ~ 2022-01-31
22020-04-01 ~ 2021-03-31
Intangible Assets - Gross Cost
Net goodwill
2 GBP2022-01-31
2 GBP2021-03-31
Development expenditure
1,345,230 GBP2022-01-31
1,326,490 GBP2021-03-31
Intangible Assets - Gross Cost
1,345,232 GBP2022-01-31
1,326,492 GBP2021-03-31
Intangible Assets
Net goodwill
2 GBP2022-01-31
2 GBP2021-03-31
Development expenditure
1,345,230 GBP2022-01-31
1,326,490 GBP2021-03-31
Property, Plant & Equipment - Gross Cost
Computers
4,757 GBP2022-01-31
4,757 GBP2021-03-31
Property, Plant & Equipment - Accumulated Depreciation & Impairment
Computers
2,754 GBP2022-01-31
2,414 GBP2021-03-31
Property, Plant & Equipment - Increase From Depreciation Charge for Year
Computers
340 GBP2021-04-01 ~ 2022-01-31
Property, Plant & Equipment
Computers
2,003 GBP2022-01-31
2,343 GBP2021-03-31
Prepayments/Accrued Income
Current
2,261 GBP2022-01-31
61,624 GBP2021-03-31
Amount of corporation tax that is recoverable
Current
288 GBP2021-03-31
Amount of value-added tax that is recoverable
Current
10,691 GBP2022-01-31
17,002 GBP2021-03-31
Trade Creditors/Trade Payables
Current
23,810 GBP2022-01-31
61,925 GBP2021-03-31
Corporation Tax Payable
Current
288 GBP2021-03-31
Other Taxation & Social Security Payable
Current
4,208 GBP2022-01-31
Other Creditors
Current
860 GBP2021-03-31
Accrued Liabilities/Deferred Income
Current
47,648 GBP2022-01-31
9,672 GBP2021-03-31
Nominal value of allotted share capital
Class 1 ordinary share
0.010 GBP2021-04-01 ~ 2022-01-31
Number of shares allotted
Class 1 ordinary share
108,300 shares2021-04-01 ~ 2022-01-31
  • OSTARA BIOMEDICAL LIMITED
    Info
    Registered number 08322823
    Stamford House, Northenden Road, Sale, Cheshire M33 2DH
    Private Limited Company incorporated on 2012-12-07 (12 years 6 months). The company status is Liquidation.
    The last date of confirmation statement was made at 2022-12-07
    CIF 0
child relation
Offspring entities and appointments
Active 0
  • Not found in our database.

qrcode

Privacy policy

© 2022-2025 Polylogarithmic Technology Ltd. All rights reserved.
Contains public sector information retrieved at 24 April 2025 and licensed under the Open Government Licence v3.0.